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Abstract
Fracture-related infection (FRI) remains a challenging complication that creates a heavy burden for orthopaedic trauma 
patients, their families and treating physicians, as well as for healthcare systems. Standardization of the diagnosis of FRI 
has been poor, which made the undertaking and comparison of studies difficult. Recently, a consensus definition based on 
diagnostic criteria for FRI was published. As a well-established diagnosis is the first step in the treatment process of FRI, 
such a definition should not only improve the quality of published reports but also daily clinical practice. The FRI consen-
sus group recently developed guidelines to standardize treatment pathways and outcome measures. At the center of these 
recommendations was the implementation of a multidisciplinary team (MDT) approach. If such a team is not available, it 
is recommended to refer complex cases to specialized centers where a MDT is available and physicians are experienced 
with the treatment of FRI. This should lead to appropriate use of antimicrobials and standardization of surgical strategies. 
Furthermore, an MDT could play an important role in host optimization. Overall two main surgical concepts are considered, 
based on the fact that fracture fixation devices primarily target fracture consolidation and can be removed after healing, in 
contrast to periprosthetic joint infection were the implant is permanent. The first concept consists of implant retention and 
the second consists of implant removal (healed fracture) or implant exchange (unhealed fracture). In both cases, deep tissue 
sampling for microbiological examination is mandatory. Key aspects of the surgical management of FRI are a thorough 
debridement, irrigation with normal saline, fracture stability, dead space management and adequate soft tissue coverage. 
The use of local antimicrobials needs to be strongly considered. In case of FRI, empiric broad-spectrum antibiotic therapy 
should be started after tissue sampling. Thereafter, this needs to be adapted according to culture results as soon as possible. 
Finally, a minimum follow-up of 12 months after cessation of therapy is recommended. Standardized patient outcome meas-
ures purely focusing on FRI are currently not available but the patient-reported outcomes measurement information system 
(PROMIS) seems to be the preferred tool to assess the patients’ short and long-term outcome. This review summarizes the 
current general principles which should be considered during the whole treatment process of patients with FRI based on 
recommendations from the FRI Consensus Group.
Level of evidence: Level V.
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Introduction
Fracture-related infection (FRI) remains a major compli-
cation that can result in permanent functional loss or even 
amputation in otherwise healthy patients. Infection preven-
tion is of utmost importance to improve patient outcome [1]. 
Despite prevention measures, FRI still occurs and causes 
significant morbidity in 1–30% of all orthopaedic trauma 
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patients [1]. For these reasons, standardization of diagnosis 
and treatment is critical to improve outcome. Most treat-
ment principles are currently based on research that has been 
performed on prosthetic joint infection (PJI). However, FRIs 
have unique features (i.e. fracture, bone healing, soft tissue 
injury) that need to be considered [2]. A first step towards 
standardization of the diagnosis was achieved by the interna-
tional consensus definition on FRI, which has recently been 
published [3]. As a next step, treatment principles for FRI 
and assessment of outcome should also become internation-
ally standardized.
This review provides a summary of the general principles 
with respect to the treatment of the patient suffering from 
FRI. We also present a step-wise approach to allow clini-
cians to address this often difficult clinical problem (Fig. 1).
General principles
Diagnosis of FRI
A first step in the work-up of the FRI patient is a well-
established diagnosis. Recently, an internationally accepted 
definition, including diagnostic criteria, was developed for 
FRI [3]. These diagnostic criteria were updated in a more 
recent publication [4]. Two levels of certainty around diag-
nostic features were defined. Criteria for infection can be 
confirmatory (infection is definitely present) or suggestive. 
The presence of confirmatory signs should prompt the ini-
tiation of a treatment course for FRI, as displayed in Fig. 1. 
Suggestive signs should motivate the medical team to further 
investigate the possibility of the presence of an FRI [3, 4]. 
Confirmatory and suggestive criteria for the diagnosis of 
FRI are listed in Table 1.
A detailed overview of the available diagnostic criteria 
is presented in affiliated articles of the FRI consensus group 
[3, 4].
Classification of FRI
Fracture-related infection can be classified according to the 
time to onset of symptoms after fracture fixation, dynamics 
of symptoms, route of infection, location, fracture stability 
and union status, host type, soft-tissue envelope and disease-
causing pathogens [6].
Time of onset of symptoms after fracture fixation is 
the most commonly used and applied modality to classify 
FRI [2]. Willenegger and Roth [7] classified FRIs as early 
(< 2 weeks), delayed (3–10 weeks) and late (> 10 weeks). 
This classification is widely adopted since it represents the 
time-dependent pathophysiologic changes of FRIs and may 
affect treatment decisions [2]. Infection presenting early 
after osteosynthesis is mainly caused by highly virulent 
pathogens (e.g. Staphylococcus aureus). The diagnosis is 
often made by clinical assessment, since these patients often 
present with classic local signs of infection as well as wound 
drainage, which may be accompanied by a local or systemic 
inflammatory reaction. In this stage, bacteria can attach to 
surfaces and form a biofilm, however, this “early” biofilm 
may still be in an ‘immature’ phase [8]. Delayed presentation 
represents a grey zone with a maturing biofilm and possible 
bone invasion of the pathogens. The delay may be due to 
less virulent organisms or to inadequate early antibiotic use, 
partially suppressing an early onset of infective symptoms. 
In late infections, a mature biofilm as well as bone necrosis 
and osteolysis may be seen, necessitating thorough debride-
ment and implant removal/exchange [2, 9]. The causative 
pathogens can be very diverse. This has been confirmed by 
various preclinical and clinical studies showing poor results 
of implant retention in late FRIs [2].
Other authors differentiated acute and chronic infections 
with a cut-off of 6 weeks after fracture fixation [10, 11]. 
There is no robust evidence for a clear time-dependent clas-
sification of FRI. Infection develops gradually and treatment 
decisions may be dictated more by the features present at 
presentation.
Several important factors, other than time after fracture 
fixation, influence the decision-making process with respect 
to the main surgical concepts of FRI treatment: debridement 
and retention versus debridement and removal or exchange. 
Recent publications have presented more elaborate classi-
fications like the “Seven-Item Comprehensive Classifica-
tion System” [12] and the BACH [13] classification system. 
However, currently no classification is available that is tai-
lored specifically to the FRI patient, is easy to use in daily 
practice and considers essential factors to guide treatment.
In the near future a consensus should be reached on which 
factors need to be integrated in a new FRI classification. The 
main purpose of such a classification should be to guide 
antimicrobial and surgical treatment decisions. It would also 
aid the identification of complex cases, where a multidisci-
plinary approach in a specialized center should be strongly 
considered [13].
Multidisciplinary approach
There is increasing evidence that multidisciplinary team-
work and collaboration between healthcare workers are 
essential to improve patient outcome [14, 15]. The use of 
antibiotic stewardship programs is already a well-known 
example of such a multidisciplinary approach for the treat-
ment of infections. They are defined as coordinated interven-
tions designed to improve and measure the appropriate use 
of (antibiotic) agents by promoting selection of the optimal 
(antibiotic) drug regimen, including dosing, duration of ther-
apy and route of administration [16]. This improves patient 
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Fig. 1  Flowchart representing the optimal treatment course for a patient with FRI
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safety, outcome, and, combined with reduced readmission 
rates, reduces healthcare costs without compromising qual-
ity of care [17–20]. According to guidelines from the Infec-
tious Diseases Society of America (IDSA), infectious dis-
ease (ID) physicians and clinical pharmacists should be the 
core members of the antibiotic stewardship program, but 
microbiologists and the input from administrative and infor-
mation personnel can also be of great importance [21]. On 
the other hand, as recently stated by Pulcini et al. [22], the 
composition of these teams is flexible and should be based 
on existing international recommendations and adapted to 
local resources and expertise. Recently, a multidisciplinary 
approach, consisting of collaboration between orthopaedic 
trauma surgeons, the hospital’s infection control department, 
nurses and anesthesiologists as primary team members, has 
been described to guide FRI prevention strategies [1]. Con-
sistent with this and the concept of antibiotic stewardship 
programs, a multidisciplinary approach for the treatment of 
FRI patients should be adopted, in which surgeons are key 
members of the team, since surgical management plays a 
critical role. However, studies within this field are scarce 
[11, 23, 24].
With respect to the treatment of FRI, the essential mem-
bers of the multidisciplinary team (MDT) require expertise 
in bone and soft tissue reconstruction, microbiology, anti-
biotic treatment and advanced imaging. Specialists with a 
background of the following disciplines can therefore be 
involved in the MDT for the treatment of FRI: orthopaedic 
trauma surgeons, ID specialists or internists, microbiolo-
gists, plastic and reconstructive surgeons, clinical pharma-
cists, musculoskeletal radiologists, nuclear medicine special-
ists, anesthesiologists, physical medicine and rehabilitation 
physicians, physiotherapists, endocrinologists/nutritionists 
and (specialist) nurses. Of course, not all members should be 
involved in every case, but a minimum of three disciplines 
including surgeons, ID specialists or internists and clini-
cal pharmacists, seems advisable. The exact composition 
of the MDT will ultimately depend on patient needs, local 
resources and preferences. A pre-operative assessment 
should precede the definitive treatment plan (Fig. 1).
Due to the high level of complexity that is often associ-
ated with FRI, and the necessity to involve multiple special-
ties in treatment decision making, it is recommended that 
physicians strongly consider the referral of complex cases 
to more specialized centers (centralization) where such an 
MDT is available.
Assessment of the patients’ general and local health 
status
Factors compromising the patient’s general health status 
increase the risk of postoperative complications. Therefore, 
the nature of treatment should be customized according to 
the patient’s general health and condition of the limb. Again, 
scientific evidence on this topic for FRI is scarce.
The host classification system that is often referred to 
was developed by Cierny et al. [25] and helps to determine 
treatment options for osteomyelitis. This classification com-
bines anatomic, clinical and radiologic features. The host 
is characterized as either class A, B or C. No systemic or 
local compromising factors are present in host class A, while 
patients in host class C are so severely compromised that 
surgical treatment would imply a far greater risk than the 
osteomyelitis in itself [25]. Bowen et al. applied the host 
classification described by Cierny et al. in combination 
with the Gustilo-Anderson classification for open fractures. 
They found that host and Gustilo-Anderson classification as 
well as fracture location and tobacco use are predictors of 
infection in open fractures [26]. The classification by Cierny 
et al. was also adapted to guide treatment for patients with 
Table 1  Diagnostic criteria for 
FRI [3, 4]
ESR erythrocyte sedimentation rate, WBC white blood cell count, CRP C-reactive protein, PMNs polymor-
phonuclear neutrophils, HPF high-power field
Confirmatory criteria Suggestive criteria
Clinical signs
 Fistula
 Sinus
 Wound breakdown
 Purulent drainage or the presence of pus
Clinical signs
 Local/systemic (e.g. local redness, swelling, fever)
 New-onset joint effusion
 Persistent, increasing or new-onset wound drainage
Microbiology
 Phenotypically indistinguishable pathogens 
identified by culture from at least 2 separate 
deep tissue/implant specimens
Laboratory signs
 Increased serum inflammatory markers (ESR, WBC, CRP)
Histopathology
 Presence of microorganisms in deep tissue 
specimens, confirmed by using specific 
staining techniques for bacteria and fungi
 Presence of > 5 PMNs/HPF in chronic/late-
onset cases (e.g. fracture nonunion) [5]
Radiological and/or nuclear imaging signs microbiology
 Pathogenic microorganism identified from a single deep 
tissue/implant specimen
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infection after total hip arthroplasty [27]. The latter classifi-
cation divides patients into three categories based on infec-
tion type (I, II or III), systemic host grade (A, B or C) and 
local wound and extremity grade (1, 2 or 3). Host status is a 
predictor of treatment outcome: a higher host grade is asso-
ciated with increased treatment failure [25–27]. However, 
this classification [27] is difficult to extrapolate to patients 
with FRI, because it includes a time component that is arbi-
trary and a local extremity status that specifically refers to 
prosthetic joints.
The American Society of Anesthesiologists physical clas-
sification (ASA score) aims to determine host general health 
prior to surgery and classifies patients into five categories 
of general medical illness, independent of the planned sur-
gical procedure [28]. Although it is a subjective tool, it is 
correlated with more objective comorbidity indices such as 
the Charlson comorbidity index and the revised cardiac risk 
index (RCRI) and has (moderate) predictive value regard-
ing perioperative risk assessment, perioperative mortality 
and complication rates as well as postoperative outcomes 
[28–31]. The inter-rater reliability and predictive value of 
this score increase when the cases correlate to the anesthe-
siologist’s specialty [32]. Because it is a simple, easy-to-
use scale that is already well known and frequently used to 
assess orthopaedic trauma patients [28–32], we recommend 
its implementation in the risk stratification of FRI patients.
In addition, evaluation of the patient’s limb status is of 
critical importance. As the clinical presentation of ortho-
paedic trauma patients is often extremely variable—ranging 
from open fractures to chronic/late onset cases—not only 
the soft tissue and neurovascular status should be assessed 
by the treating surgeon, but also the overall functionality of 
the affected limb.
Host optimization
Depending on the assessment of the general and local health 
status, the patient should, if possible, be optimized. Comor-
bidities like poor nutritional status, obesity, age-related dis-
eases and all additional factors that influence wound healing 
can adversely affect treatment outcome [33]. In addition, 
regardless of the type of surgery, compliance with general 
infection prevention measures (e.g. preoperative washing 
and decontamination, appropriate surgical skin antisepsis, 
etc.) remains an important factor (Fig. 1) [1].
Regarding host optimization, it is known that smoking 
delays wound healing, and therefore the patient should be 
encouraged to cease smoking as soon as possible prior to 
surgery and at least for the duration of the healing process 
[34, 35]. Tissue perfusion and oxygenation are also key 
components in wound healing [33, 36, 37]. Severe arterial 
insufficiency should be corrected prior to definitive treat-
ment. Absent pulses should be investigated with Doppler 
studies or angiography, and angioplasty performed if this 
is likely to improve compromised arterial perfusion. Fur-
thermore, any reversible cardiovascular or pulmonary con-
dition or fluid imbalance that may interfere with adequate 
perfusion and oxygenation should be addressed prior to 
surgery [33, 36].
Endocrine disorders, such as diabetes mellitus, may also 
compromise surgical outcome [33, 38, 39]. Surgery induces 
a stress on the body resulting in the release of catechola-
mines, cortisol and glucagon, thereby causing surgery-
induced hyperglycemia [33, 40]. To avoid intraoperative 
extremes regarding hypoglycemia and hyperglycemia, 
patients with diabetes should be examined by a dietitian and 
endocrinologist prior to surgery if they are not already in fol-
low-up. If necessary, their nutritional status and insulin regi-
men should be corrected preoperatively [33]. Hemoglobin 
A1c (HbA1c) is a parameter used to determine the level 
of glycemic control in diabetes mellitus [38, 39]. The risk 
of infection in patients with diabetes mellitus increases as 
the perioperative HbA1c increases [38]. In patients without 
diabetes, hyperglycemia is also associated with poor clinical 
outcomes [41]. One should consider that up to one-third of 
intraoperative hyperglycemia cases occur in patients without 
diabetes [39, 40] and that, more specifically, for orthopaedic 
trauma patients admitted to the ICU, studies demonstrated 
that stress-induced hyperglycemia has a significant inde-
pendent association with infection [42–46]. Therefore, glu-
cose levels should be monitored intraoperatively in patients 
with and without diabetes and should be kept between 
140 mg/dL (7.8 mmol/L) and 180 mg/dL (10 mmol/L) [40, 
47, 48].
Malnutrition implies an imbalance of nutrients and cal-
ories required to sustain good health and development. It 
includes undernutrition, micronutrient deficiencies and obe-
sity [49]. Obesity (body mass index ≥ 30 kg/m2), entails a 
risk for postoperative complications such as infection, hema-
toma, wound dehiscence, and, in case of soft tissue repair, 
flap necrosis [50, 51]. However, as surgery increases the 
patient’s metabolic demands, drastic weight loss prior to sur-
gery may not be advisable [33]. A recent systematic review 
by Ernst et al. [52] suggests that patients who are malnour-
ished at the time of trauma have more complicated hospital 
stays and increased complication rates with delayed or prob-
lematic wound healing. Patients with advanced age, recent 
significant weight loss and a lack of nutritional support are at 
greater risk of nutritional deficiency [33, 53]. Serum protein 
markers and weight assessment are conventional methods 
to assess nutritional status [33, 54]. If the patient appears 
nutritionally at risk, oral nutritional supplementation can 
be considered prior to surgery, in consultation with profes-
sionals. If the malnourishment is severe, the combination of 
oral nutritional supplementation with (par)enteral nutritional 
support should be considered prior to surgery. In such cases, 
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if the patient’s clinical status allows it, it is advisable to delay 
surgery until the nutritional status is under control [53, 54].
Fracture-related infection is often connected to impaired 
fracture healing. A strategy that is sometimes suggested to 
improve bone healing is vitamin D supplementation. Vita-
min D is an important factor in bone health, muscle func-
tion and the immune system [55–57]. Unfortunately, hypo-
vitaminosis D is common and is associated with low intake, 
inadequate sun exposure and intestinal malabsorption. Bogu-
novic et al. [58] retrospectively reviewed 723 patients under-
going orthopaedic surgery. In this study, 43% of patients 
had insufficient serum vitamin D levels of which 40% had 
vitamin D deficiency. The authors concluded that, given the 
importance of vitamin D in musculoskeletal health, such low 
levels may negatively impact patient outcomes [58]. Brinker 
et al. performed a study on trauma patients with unexplained 
non-unions. Although no causative link between the pres-
ence of endocrine or metabolic abnormalities and the devel-
opment of non-union could be found, there was evidence 
that underlying metabolic or endocrine disorders (such as 
vitamin D deficiency or thyroid-related problems) are com-
mon findings in unexplained non-unions [59]. The fact that 
endocrine disturbances seem to occur more often in this 
population might suggest that, in cases where the reason 
for non-union is unclear, referral of the patient to an endo-
crinologist can be considered, followed by possible supple-
mentation and/or treatment of an underlying disorder. With 
this in mind, standard vitamin D supplementation for acute 
fracture patients could be considered. Indeed, it is known 
that supplementation can safely increase vitamin D serum 
levels and some studies also report increased bone mineral 
density. However, these studies focus on postmenopausal 
women who received vitamin D and calcium supplements 
over several weeks [60]. A single early high-dose vitamin 
D supplementation, as assessed in a recent prospective ran-
domized controlled trial, does not seem to affect the frac-
ture union rate [61]. In general, the evidence regarding the 
effect of standard vitamin D supplementation for all fracture 
patients—or supplementation with any other vitamin—on 
fracture healing and overall outcome remains scarce [60]. 
Therefore, it is only possible to recommend supplementa-
tion in consultation with qualified members of the MDT 
(e.g. endocrinologist, nutritionists) for those patients who 
are considered at risk, like postmenopausal women.
Many of the above-mentioned points are applicable not 
only to the treatment of FRI, but to all surgical subspecial-
ties. Overall, preoperative host optimization is not always 
possible in FRI patients, especially in unstable fracture 
cases or in situations where the patient has become septic. 
The host status should be continuously assessed throughout 
the treatment course, as displayed in Fig. 1, and, depend-
ing on the assessment, optimization should start as soon as 
possible.
Shared decision making
It is important that the treatment plan is established together 
with the MDT and adequate information is provided to the 
patient. FRI patients often suffer from long-term disability 
due to multiple reoperations, followed by prolonged hospital 
stays. From a psychological point of view, it is important 
that patients are aware of all the available treatment options 
including their benefits, risks and potential outcomes. In 
patient-centered care it is essential that healthcare profes-
sionals as well as patients can access all available informa-
tion to make an informed decision, while considering the 
patient’s values and the healthcare professionals’ expertise 
or recommendations [62]. Shared decision-making is defined 
as the process by which the patient (or his/her significant 
others) makes the healthcare choices together with one or 
more healthcare professionals (Fig. 1) [62].
Adequate counselling of patients entails a good knowl-
edge of the most recent scientific evidence regarding treat-
ment of FRI. Furthermore, it is important to schedule 
sufficient time to allow true patient involvement in this 
decision-making process.
Surgical concepts
Primary aims and key concepts
One of the main features that distinguishes FRI from PJI is 
the presence of a fracture (i.e. instability). Fracture stabil-
ity is of paramount importance not only to achieve fracture 
union, but also for prevention and treatment of infection 
[63]. The classical experimental studies of Rittmann and 
Perren [64], showed the positive influence of stability on 
infection in fracture care. They stated that the advantage of 
the stabilizing effect of implants outweighs the disadvantage 
of a foreign body effect. As fracture fixation devices primar-
ily target fracture consolidation, they can be removed after 
the fracture has healed (in contrast to PJI), thereby removing 
the biofilm and resulting in a high probability of eradication 
of the infection and thus prevention of chronic infection/
osteomyelitis. This means that complete eradication of infec-
tion may not always be the initial goal. Suppressive therapy 
with antibiotics has been established as an alternative in 
certain cases [2, 65].
Based on this, two main surgical concepts should be con-
sidered. The first concept consists of debridement, antimi-
crobial therapy and implant retention (DAIR). The second 
consists of debridement, antimicrobial therapy and implant 
removal—if the fracture is healed—or implant exchange (in 
one or multiple stages)—if the fracture is not healed. In both 
cases, deep tissue sampling for microbiological examina-
tion is mandatory and adequate soft tissue cover must be 
achieved.
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In every case, special attention should be paid to stability 
of the fracture in order to obtain union and treat the infection 
[63, 66]. Whether the implant should be removed or not, 
depends on several factors. The implant should, for exam-
ple, be removed or exchanged (for new internal fixation or 
converted to external fixation) in cases where the implant 
and fracture are unstable, reduction is not acceptable or in 
severely compromised cases with poor host physiology. In 
isolated cases in which healing cannot be achieved due to a 
compromised host or due to an extensive infection, amputa-
tion or a nonsurgical approach, with or without (lifelong) 
antibiotic suppression may be the only treatment alternative 
(e.g. in elderly patients with poor host physiology) [2]. The 
primary aims of surgical treatment of FRI [2] are listed in 
Table 2.
Tissue sampling
Confirmation of infection is achieved by culture of micro-
organisms from deep tissue samples, metal implants or his-
topathological evaluation of deep tissue [4]. All cases of 
FRI require tissue sampling. Samples should be obtained 
early in the surgical procedure, before contamination occurs. 
Preferably 5 deep tissue samples should be taken with sepa-
rate instruments, from sites around the fracture and adjacent 
to any implants [4]. The combination of microbiology and 
histopathology has been shown to improve the accuracy of 
diagnosis and allow more specific antimicrobial therapy 
[66–69].
Debridement and irrigation
Debridement remains an important surgical tool in the 
treatment of FRI. In general, debridement should include 
the excision of necrotic (i.e. non-bleeding) bone or tissue, 
excision of poorly perfused tissue (it will not contribute to 
wound healing and antibiotic delivery) and removal of all 
non-essential foreign bodies (e.g. broken screws, sutures) 
[2].
A question that sometimes leads to debate is the extend 
of debridement (i.e. bone resection). Although ‘oncologic 
resection’ of infected bone has been proposed [2], a more 
judicious approach is recommended with excision of bone 
until uniform punctate bleeding is encountered [70]. This 
is based on the hypothesis that infected bleeding bone is 
viable and can heal with antibiotic therapy (i.e. systemic 
and local).
Irrigation aims at decreasing the bacterial load and 
removal of loose debris. Most of the clinical research 
within this field comes from open fracture studies [71, 72]. 
It should be performed using normal saline at low pressure 
to avoid bacterial seeding in soft tissue and bone [73]. The 
use of additives is currently not advised as they may add to 
cell toxicity [71, 74]. A sufficient amount (i.e. depending 
on the anatomic location) of irrigation fluid should be used 
in order to thoroughly clean the surgical field and to lower 
the bacterial load after debridement.
Local antimicrobial therapy and dead space management
Depending on the amount of non-viable bone, adequate 
bone resection may create a tissue defect that must be 
managed. Ideally, this defect should be filled with healthy 
living tissue which will allow ingress of neovascularisa-
tion, delivery of systemic antimicrobials and host immune 
cells. The application of local antimicrobials is a powerful 
adjunct in the treatment of FRI and should be considered, 
especially in cases with a remaining bony defect or ‘dead 
space’ [75]. Local antibiotics may be particularly effective 
in chronic/late onset infections, where the perfusion of 
systemic antibiotic is greatly reduced due to chronic tissue 
scarring. A recent systematic review [76] of contaminated 
open fracture wounds showed a considerable risk reduc-
tion if additional local antibiotics were applied. Although 
PMMA was the most studied material, the prophylactic 
effect of absorbable carriers for local antibiotic delivery 
showed also promising results [76].
Indications for the use of specific types of antimicro-
bials, application techniques, dosages, elution properties 
and pharmacokinetics are poorly defined in the clinical 
setting leading to arbitrary variation in practice which is 
becoming a significant issue in orthopaedic trauma surgery 
[77, 78].
A detailed overview of the available local antimicrobi-
als, including recommendations on their indications and 
doses, is presented in an affiliated article of the FRI con-
sensus group [79].
Bone defect treatment
Segmental bone defects of long bones are challenging, espe-
cially when associated with infection [80]. A systematic 
review concluded that the optimal treatment depends on the 
surgeon’s expertise and the unique situation of the patient 
(e.g., infected defect size, defect location, soft-tissue enve-
lope, medical comorbidities, patient compliance) [80]. A 
Table 2  Primary aims for the surgical treatment of FRI [2]
1. Fracture consolidation
2. Eradication of infection as the final outcome (in certain cases, 
initial suppression of infection until fracture consolidation is 
achieved)
3. Healing of the soft-tissue envelope
4. Restoration of function
5. Prevention of chronic infection/osteomyelitis
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more recent systematic review on critical-sized bone defects 
in patients suffering from an FRI confirmed this conclusion 
[81].
Soft tissue management
Meticulous debridement of all non-viable tissue may result 
not only in bone defects, but also in major overlying soft tis-
sue loss. It is important that orthopaedic trauma surgeons do 
not limit bone or soft tissue excision due to concerns about 
their ability to reconstruct the soft tissue envelope. Prior 
discussion with a plastic surgeon will allow the excision to 
be performed without concern about skin closure.
Data on the optimal timing of soft tissue coverage in FRI 
patients is limited. In cases where the soft tissue is severely 
compromised, a two-stage procedure may be necessary. 
However, if possible, a one-stage procedure can be consid-
ered and is often possible in chronic/late onset infections 
[82]. Single-stage treatment requires considerable logisti-
cal organization of teams. Development of good multidis-
ciplinary collaboration is important. In any case, soft tissue 
coverage over infected fractures should be provided as soon 
as practically possible.
The choice of soft tissue reconstruction is based on many 
parameters. Local muscle flaps are useful in the proximal 
tibia and distal femur but the lower third of the tibia will 
require free tissue transfer. Although a recent study did indi-
cate that a muscle flap had a lower non-union rate than a fas-
ciocutaneous flap in open fracture cases [83], there is little 
evidence to recommend one specific flap type over another 
in FRI cases [84–88].
Finally, in the specific scenarios where multiple proce-
dures are planned, the use of negative pressure wound ther-
apy (NPWT) should only be used as a temporary bridge to 
definite soft tissue coverage. It should not be used for more 
than approximately 1 week and cannot serve as an alterna-
tive to definitive soft tissue reconstruction in FRI. Prolonged 
NPWT may lead to colonization with resistant organisms 
and possibly increased infection rates [89].
Antimicrobial therapy
In most cases, antimicrobial therapy can be delayed until 
after deep tissue sampling. Immediate antibiotic therapy is 
only given to patients with sepsis and after obtaining blood 
for culture.
Empiric IV antimicrobial therapy should be started as 
soon as tissue samples are taken and maintained until defini-
tive culture results are available. The choice of empiric ther-
apy depends on the local epidemiology of antibiotic resist-
ance rates, antibiotic formularies and the risk factors of each 
individual patient (i.e. previous antibiotics, co-morbidities, 
allergies, previous hospitalisations, previous debridements 
at the same site, previously recovered pathogens). Initially, 
empiric therapy should be broad spectrum, including a lipo/
glycopeptide and an agent against gram-negative bacilli. 
Thereafter, it should be adapted according to culturing 
results as soon as possible. In every case, as soon as the 
culture results become available, antibiotic therapy should 
be adjusted accordingly (Fig. 1).
Duration of antimicrobial therapy is controversial and 
not well investigated. Overall, regimes of 6–12 weeks are 
common and should be decided with advice from the MDT. 
A recent randomized controlled trial showed that patients 
treated with up to 7 days of IV antibiotics followed by oral 
therapy had the same outcome as those with prolonged IV 
therapy (usually 6–12 weeks) [90].
When a segmental excision has been performed and all 
dead and infected tissue removed, it may be sufficient to give 
2 weeks of antimicrobial therapy to eradicate the residual 
contamination in the soft tissues. However, in case of sup-
pressive treatment, therapy should be continued until frac-
ture union.
In cases with a low suspicion of infection, it is safe to give 
empiric antibiotic therapy until culture results and histopa-
thology is available. Therapy should be stopped as soon as 
infection is ruled out.
As presented in Fig. 1, all FRI patients should have a 
baseline blood analysis available, especially patients who 
will receive IV antimicrobial therapy, including baseline 
inflammatory markers [e.g. C-reactive protein (CRP)], full 
blood count, electrolytes and liver- and renal function tests. 
Depending on the type of antibiotic and local preferences, 
some specific blood parameters (e.g. liver function tests for 
rifampicin, electrolyte levels and full blood count for fluoro-
quinolones, etc.) should be monitored at least twice weekly, 
as common side effects of high-dose IV antibiotics include 
bone marrow suppression, hepatitis and nephrotoxicity. 
Sometimes, it is not possible to use oral antibiotic therapy, 
mainly due to intolerance or microbial resistance. In these 
cases, an out-patient parenteral antibiotic therapy (OPAT) 
service reduces costs and can support patients at home, with 
monitoring of therapy.
A more extended review with recommendations regard-
ing antimicrobial therapy in FRI patients is presented in an 
affiliated article of the FRI consensus group [91].
Rehabilitation and follow‑up
Early individualized functional rehabilitation is a critical 
aspect for every orthopaedic trauma patient and particu-
larly when infection arises. Therefore, physiotherapists and 
physical medicine and rehabilitation physicians play a key 
role (Fig. 1). As FRI often entails a prolonged treatment 
pathway, psychological support should also be available. In 
these cases, specialist nurses can play a key role.
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Patient optimization principles, as discussed in “Host 
optimization”, should also be implemented in the post-
operative and follow-up period. A follow-up of minimum 
12 months after cessation of (surgical and antibiotic) ther-
apy is required. The follow-up frequency depends on local 
preferences and policies and on the extent of the infection. 
Follow-up outpatient visits generally consist of a wound 
inspection, radiological evaluation of the fracture and moni-
toring for complications or recurrence of infection. In case 
of deterioration of the patient’s health status (e.g. sepsis), 
CRP levels can help the decision-making process, although 
physicians should be aware that the evidence for the use of 
serum markers as diagnostic and follow-up parameters is 
scarce [92].
Regarding the standard removal of implants after con-
solidation/healing of a sustained FRI, currently insufficient 
evidence exists to recommend this at a routine basis.
Standardized patient outcome measures
Clinical versus patient‑reported outcomes
Standardized outcome measures for FRI patients are cur-
rently lacking. Such outcomes include clinical outcomes, 
functional outcomes, general health-related outcomes, and 
satisfaction with the process of care. Clinical outcomes 
(such as range of motion, radiographic union, implant loos-
ening, and ongoing or recurrent infection) have been the 
focus of clinical research in orthopaedic surgery [93, 94]. 
However, good clinical outcomes do not necessarily indi-
cate a good return to function. Functional outcomes primar-
ily involve the patient at the most complete level, not as a 
joint or condition but as an individual in society [95–97]. 
Health-related quality of life involves patients’ perception of 
how they are functioning as affected by their overall health. 
Covered areas of individual function include mental health, 
social function, role function (i.e., worker, spouse, parent), 
physical function, and activities of daily living [98, 99]. 
Patient-reported outcomes will become more important for 
reporting quality metrics, for insurance companies, and for 
the internal evaluation of patient outcomes, as well to be 
able to compare different anatomic sites. No official rec-
ommendation on this topic has been made by international 
organizations for trauma patients and further research on this 
topic is warranted.
CAT instruments
Computer adaptive testing (CAT) greatly decreases the 
patient burden to acquire data. The well-established Patient 
Reported Outcomes (PROs) used in trauma that do not 
involve CATs are the SF-36, the Sickness Impact Profile 
(SIP), the Western Ontario and McMaster Universities 
Arthritis Index (WOMAC), the Nottingham Health Profile, 
Quality of Well Being (QWB), Musculoskeletal Functional 
Assessment (MFA) and the EQ-5D [100]. Furthermore, 
within musculoskeletal health, multiple scores have been 
developed to evaluate individual body parts or joints. These 
global and injury-specific instruments have been validated 
and used as qualitative assessments of patients’ overall health 
and function. They have the advantage of being consistent 
across patients and being repeatable measures. However, they 
have the disadvantage of having to repeat all questions to 
each respondent at each evaluation, which leads to patient 
burden, subject fatigue, and subsequent loss of compliance 
or follow-up [101]. In contrast, CAT provides the opportunity 
to collect equally accurate assessments of patient function 
while asking far fewer questions, which should enable the 
collection of data from more patients, more often, with less 
patient fatigue in the data collection process.
Computer adaptive testing utilizes “item response theory” 
and is considered a dynamic assessment. This approach ena-
bles patients to answer questionnaires with far fewer ques-
tions with near equal specificity of a patient’s level of func-
tion and sensitivity to changes in function as the full version 
of scientifically developed questionnaires.
The most widely employed patient-reported outcome 
(PRO) CAT is the ‘patient-reported outcomes measurement 
information system’ (PROMIS) instrument, the development 
of which was funded and backed by the NIH. The PROMIS 
scores focus on domain-specific assessment (physical func-
tion, mental health, etc.), rather than the injury-specific 
focus of some legacy instruments. By providing equal or 
improved accuracy of assessment with substantially less 
patient burden, PROMIS is a research instrument for assess-
ment of lower extremity trauma patients with or without 
an FRI. Subsequent evaluation of PROMIS for the upper 
extremity has also been encouraging [102, 103]. Other CATs 
exist, but are less widely employed to date and warrant fur-
ther investigation.
Due to the significant decrease in patient burden and 
equal ability to thoroughly evaluate patients function and 
changes in function, computer adaptive testing is likely to 
be common in future outcome assessments, also for FRI 
patients. At this time, it appears that NIH PROMIS is the 
most likely future assessment tool for most orthopaedic 
trauma research.
Conclusion and recommendations
FRI remains a challenging complication. To improve overall 
outcome, we should aim for standardized recommendations 
for diagnosis and treatment. This review focuses on deliver-
ing these recommendations (Table 3), in combination with 
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an optimal treatment pathway for FRI patients (Fig. 1) based 
on up-to-date scientific evidence and expert opinion.
Starting from the first patient contact, a full diagnostic 
work-up should be performed, considering the recently pub-
lished diagnostic criteria [3, 4]. The presence of suggestive 
signs should encourage the MDT to further investigate the 
probability of an FRI and to look for confirmative signs. 
The presence of confirmative signs should prompt treatment, 
based on host type and a multidisciplinary approach. If the 
patient is otherwise healthy the treatment plan can be started 
immediately. In the case of compromised hosts—based on 
the ASA score and assessment of the local health status—
patient optimization should be initiated as soon as feasible, 
depending on the clinical status (e.g. sepsis, severe bony 
instability) of the patient.
Surgical treatment entails multiple key aspects (e.g. sam-
pling, debridement, local antimicrobial therapy, soft tissue 
management, bone defect reconstruction). A judicious well-
planned debridement remains one of the cornerstones in the 
treatment of FRI. The surgeon should give special atten-
tion to obtaining uncontaminated deep tissue samples for 
microbiology and histopathology. Immediately after tissue 
sampling, empiric broad-spectrum antibiotics should be 
started in case an FRI is suspected. Based on the result of 
tissue cultures and the corresponding antibiogram(s), anti-
biotic therapy needs to be adapted. OPAT can be considered 
in cases where longstanding IV antibiotic therapy is neces-
sary. Regular follow-up is needed to monitor therapy, iden-
tify complications early and maximize functional outcome. 
Finally, follow-up of a minimum 12 months after cessation 
of (surgical and antibiotic) therapy is recommended.
Clinical outcomes of fracture union and absence of infec-
tion recurrence are important, but standardized patient-
reported outcome measures are also critical.
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